Live Breaking News & Updates on Mendus Ab Publ Stock Exchange

Stay updated with breaking news from Mendus ab publ stock exchange. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Mendus receives ATMP certificate from European Medicines Agency supporting its lead pipeline program vididencel

POSITIVE RECOMMENDATION BY COMMITTEE FOR ADVANCED THERAPIES CONFIRMS QUALITY OF THE MANUFACTURING PROCESS AND PRECLINICAL DATA SUBMITTED Mendus AB , a biopharmaceutical company focused on. | June 19, 2023 ....

Erik Manting , Mario Brkulj , Leopold Bertea , Corey Davis , European Medicines Agency , Valency Communications , Committee For Advanced Therapies , Lifesci Advisors , Advanced Therapy Medicinal Product , Advanced Therapies , Chief Technology Officer , Nasdaq Stockholm , Sci Advisors , Mendus Ab Publ Stock Exchange , Press Release , Ocused Immu Se0005003654 ,

Mendus : Item 8. The board of directors complete proposal on approval of directed issue

The board of directors of Mendus AB , reg. no 556629-1786, complete proposal for resolution on approval of directed issue of shares and warrants

. | June 9, 2023 ....

Flerie Invest , Pareto Securities , Mendus Ab Publ Stock Exchange , Press Release , Nd Immu Se0005003654 ,

Mendus : The board of directors resolution on directed issue

The board of directors of Mendus AB , reg. no 556629-1786, resolution on directed issue of shares and warrants

. | June 9, 2023 ....

Flerie Invest , Pareto Securities , Mendus Ab Publ Stock Exchange , Press Release , Nd Immu Se0005003654 ,

Mendus : Item 7. The board of directors complete proposal on approval of rights issue

The board of directors of Mendus AB , reg. no 556629-1786, complete proposal for resolution on approval of issue of shares and warrants with preferential rights for existing. | June 9, 2023 ....

Euroclear Sweden , Rights Issue , Mendus Ab Publ Stock Exchange , Press Release , Or Immu Se0005003654 ,

Mendus AB: Mendus and NorthX Biologics to enter into strategic cell therapy manufacturing alliance supported by new investor Flerie

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announces that it has entered into a manufacturing alliance with NorthX Biologics AB . NorthX is a. | June 8, 2023 ....

City Of , United Kingdom , Corey Davis , Erik Manting , Helena Strig , Van Herk , Mario Brkulj , Leopold Bertea , Thomas Eldered , Manufacturing Organization , Valency Communications , Contract Development , National Swedish Innovation Hub , Fourth Swedish National Pension Fund , Lifesci Advisors , Northx Biologics , Flerie Invest , Van Herk Investments , Chief Executive Officer , Mendu Board , Extraordinary General Meeting , Acute Myeloid Leukemia , Chief Technology Officer , Sci Advisors , Nasdaq Stockholm , Mendus Ab Publ Stock Exchange ,